Clinical labs,
bring new volume to your bench.

Humans Nexus is the neutral platform that routes new, incremental test volume to your laboratory (collected at the practice or at home, delivered under documented chain of custody, ready to accession). You run the science; we carry everything around it.

The commercial point

New demand, not a reshuffle.

The platform recruits practices, clinics and digital-health partners and concentrates their demand on the labs it connects, collected at the point of care or at home. That is incremental throughput your laboratory would not otherwise see: microsampling for laboratories, delivered as new volume rather than a reshuffle of the work you already run.

The differentiator

We own no lab. We will never compete with you for a sample.

Because we run no laboratory of our own, the platform has no reason to steer volume anywhere but to you, unlike platforms that operate their own lab while asking yours to join. Infrastructure shouldn’t compete with the labs it connects.

First principle

Your lab, your menu.

Humans Nexus does not operate a laboratory. We are the infrastructure between the patient and your lab (regulated collection kits, clinical-grade logistics under documented chain of custody, and software that lands structured orders and results in your LIS). The test stays yours. The accreditation stays yours. The relationship with the result stays yours.

We never compete with your lab. Our only role is to carry remote demand to the labs that run the tests, which is exactly why it is safe to build remote volume on the platform.

The problem

The volume you can’t reach.

Your menu is validated and accredited, but it stops at the clinic door. Every patient who won’t, or can’t, come in for a venous draw is a test you never run. Remote and microsampling demand is growing, and without a collection platform it flows past the laboratory entirely.

Collection is the ceilingThe analytics are solved; the bottleneck is getting a clinical-grade sample from the home to the bench.
Integration is dauntingStanding up kits, logistics, identity and result routing in-house is a build most labs can’t justify.
Demand leaks awayDecentralised trials, digital-health and at-home programmes need remote collection, and route to whoever already has the platform.
What the platform gives you

Reach, without the build.

Extend your existing, accredited menu to the patient’s home (and capture remote and microsampling volume you cannot reach today) without building collection infrastructure yourself.

Extend your menu homeRun your accredited assays on remotely collected samples
One platform, many devicesCapillary blood, saliva, urine and stool on a single platform
Zero integration burdenKits, logistics and result routing are ours to operate
Accreditation retainedPer-parameter accreditation stays with your laboratory

The remote sample arrives stabilised, identity-matched and documented (pre-analytical integrity you can defend). See how we protect the sample →

How it works

From home to your bench.

STEP 01Order & ship

A partner programme orders a regulated kit through one integration. It ships to the patient with identity matched at the point of collection.

STEP 02Collect & return

The patient collects at home and returns the sample under documented chain of custody (stabilised, sealed and tracked, with controlled-temperature transport where the panel requires it).

STEP 03Accession & run

Your laboratory accessions the sample and runs the accredited assay. Structured results flow back through the same integration to the ordering programme.

See the lab network → · See Pulse →

What’s covered

Every matrix you run.

The platform covers every sample type your menu needs (on regulated kits, with stabilisation matched per analyte).

SampleRemote formatsTypical use
Capillary bloodLiquid, VAMS, dried blood spotChemistry, TDM, serology, HbA1c
SalivaStabilised collectionHormones, identity, DNA
UrineDried & liquidMetabolites, fertility, renal
StoolAmbient-stableMicrobiome & FIT

Explore microsampling → · See devices & kits →

Credibility

Validated, where it counts.

Remote, patient-collected microsampling is not experimental. Validated remote use is published across at-home HbA1c, pediatric pharmacokinetics, therapeutic drug monitoring, anti-doping and decentralised trials, and published remote programmes report high sample-return compliance. The platform is built so that the pre-analytical phase (the part outside your walls) is documented to the same standard as the assay inside them.

□ Photo · Laboratory accessioning
An accredited lab receiving a sealed, identity-matched remote sample at accessioning, the moment the custody chain closes. Editorial, clinical, soft light.
Replace with your asset · 16:9
Handle everything

New volume arrives without new work.

New demand should not land as extra load on your desk. The platform runs everything around the test (onboarding, invoicing, collection and payment) so all your laboratory does is accession the sample and run the assay.

01Verify & onboard the practices

Licences and documents are collected; you validate each as a new client, exactly as you instruct.

02Invoices in your name

Issued via a licensed e-invoicing solution, with delivery into your accounting and LIS as you connect.

03You’re paid first

A licensed payment operator collects and settles to your account first, zero credit risk on the channel.

04Kits provided

CE-marked, IVDR/MDR-compliant collection kits, pre-positioned at the practice.

05Logistics run for you

Chain-of-custody transport on a medical courier, with attestation and tamper-evident tracking.

06Results routed back

Your clean, structured results returned to the practice and the patient.

The billing platform

You stay the supplier. We carry the paperwork.

You remain the principal and the invoicing party; the practice is your customer and owns the patient; we never become the seller of the test. Invoices are issued in your name and are compliant with EU and German B2B e-invoicing from day one.

Since 2025 · receivingAlready mandatory. A German business must be able to receive a structured e-invoice today.
From 2027 · issuing, above the thresholdLarger businesses must issue in structured EN 16931 formats. Paper and plain PDF stop qualifying.
From 2028 · issuing, everyoneNo turnover threshold left. Every B2B invoice is structured, archived and auditable.

What a laboratory faces alone is building structured e-invoicing in-house, retiring paper and PDF, arranging compliant archiving and testing it before a hard deadline (for a channel of small invoices it did not want to administer in the first place). Every invoice on this channel is born compliant. No project, no deadline, nothing built.

VAT and e-invoicing specifics are confirmed by written opinion per market before publication.

What we earn

A transparent platform fee.

We earn one transparent platform fee on the volume we bring you (never a mark-up on your test, and)never a cent on the business you already have. We do not resell the medical service: you remain the principal and the invoicing party throughout.

Your existing accounts stay yours. Permanently.

The business you already had carries no fee, ever (whatever volume it sends, however long it stays). That is fixed with you before anything goes live.

The platform fee applies only to demand the network creates. If we did not bring it to you, we do not earn on it.

The anchor laboratory

One laboratory per region.
Agreed, not applied for.

Decentralised collection is moving laboratory volume out of the clinic and onto platforms. In each region, one laboratory is named publicly as the anchor: the one the network is built around rather than merely routed to. Live and Connected you reach on your own, and both are free. Anchor is reached by agreement, and it is a role rather than a rung.

Named in the regionPublicly, on our site and yours. The laboratory practices in that market are introduced to first.
First call on new demandNew practices and programmes come to you before the network is widened.
Panels built togetherMethod and panel developed jointly, with the validation work funded between us rather than billed to you.
Volume commitment, both waysYou commit capacity; we commit volume. Neither side is guessing at the other’s plan.
Joint market entryWe open a market together (your accreditation and reputation, our platform and demand).
A say in the roadmapWhat gets built next, and in what order. Anchor laboratories are in that conversation before it is settled.

Nothing below it requires a conversation, and nothing at any level costs anything to reach. See what each level includes →

Register your lab

Tell us what you run.

Share a few details and we will map new remote and point-of-care volume to your bench. What we capture at onboarding:

Lab & countryLaboratory name and country of operation
AccreditationsISO 15189 · CLIA · CAP
Matrices runBlood, stool, urine, saliva
Dried-sample capabilityVAMS · dried blood spot
LIS & accounting stackYour systems for orders, results and invoicing
Integration readinessHow you exchange orders and structured results
Target programmesThe new-volume programmes you want to anchor

Good to know.

Will Humans Nexus compete with our laboratory?

No. We do not operate a laboratory and we never compete with the labs we integrate. Our only role is to carry remote, patient-collected samples to your bench and route structured results back. The test, and the relationship with the result, stay yours.

Do we keep our accreditation?

Yes. Per-parameter accreditation stays with your laboratory. Humans Nexus provides the regulated collection kit, clinical-grade logistics and the platform; your lab runs the accredited assay exactly as it does today.

How much integration work is required?

The platform is designed for minimal burden. Kits, logistics, identity and result routing are operated by Humans Nexus; your laboratory accessions the sample and exchanges orders and results through one integration. See Pulse →

Is a remotely collected sample reliable for our assays?

For a validated panel, yes. Capillary and dried formats are designed to deliver clinical-grade results from low volumes, with stabilisation matched per analyte and controlled-temperature transport where required, documented from collection to accessioning. See logistics & chain of custody →

Which sample types can we receive?

Capillary blood (liquid, VAMS and dried blood spot) plus saliva, urine and stool, all on the same platform. Explore microsampling →

Do we keep our accreditation and VAT status?

Yes. Per-parameter accreditation stays with your laboratory, and you remain the principal supplier and the invoicing party (we never become the seller of the test). What that means for your VAT position is confirmed by written counsel per market, because it turns on the panel rather than on the structure.

How are we paid?

First, before any payout (a licensed payment operator collects and settles to your account first, so there is zero credit risk on the channel).

Bring remote volume to your bench.

Become a lab partner and extend your accredited menu to remote collection, on a platform that never competes with you.